Press Releases Blue Water Ventures International, Inc.

Equities

BWVI

US09609E1055

Market Closed - OTC Markets Other stock markets 01:28:09 17/05/2024 am IST			5-day change	1st Jan Change
0.035 ^USD	+194.12%		+122.93%	-43.55%

2023	Psycheceutical Bioscience, Inc. Announces Chief Executive Officer Changes	CI
2023	Psycheceutical Bioscience, Inc. Appoints Neilank K. Jha as Its New Executive Chairman	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Veru Sells ENTADFI Business for $20 Million Plus up to an Additional $80 Million from Sales Milestones	21/23/21	AQ
Psycheceutical Bioscience, Inc. Named a 2023 Top 10 Biotech Startup by Life Sciences Review	13/23/13	PR
Psycheceutical Hosts MAPS Founder and Psychedelic Industry Leader Rick Doblin at Its Drug Development Lab	29/23/29	GL
Psycheceutical Bioscience, Inc. Announces Observational Research Results for NeuroDirect™ Ketamine Topical Cream in Treating PTSD	21/23/21	GL
Psycheceutical Bioscience, Inc. Announces Observational Research Results for NeuroDirect™ Ketamine Topical Cream in Treating PTSD	21/23/21	AQ
Psycheceutical to Conduct the First Ever Phase I and II Clinical Trials of a Novel Ketamine Topical Cream to Treat PTSD	15/23/15	GL
Psycheceutical to Conduct the First Ever Phase I and II Clinical Trials of a Novel Ketamine Topical Cream to Treat PTSD	15/23/15	AQ
Psycheceutical Announces Completion of Pre-IND Meeting with FDA for Topical Ketamine Drug to Treat PTSD	02/23/02	GL
Psycheceutical Announces Completion of Pre-IND Meeting with FDA for Topical Ketamine Drug to Treat PTSD	02/23/02	AQ
Psycheceutical Bioscience Provisional Patent Application for Novel Ketamine Topical for the Treatment of PTSD	26/23/26	GL
Psycheceutical Bioscience Provisional Patent Application for Novel Ketamine Topical for the Treatment of PTSD	26/23/26	AQ
Psycheceutical Announces Julian Bailes, M.D. as Board Member and Chief Medical Officer	11/23/11	GL
Psycheceutical Announces Julian Bailes, M.D. as Board Member and Chief Medical Officer	11/23/11	AQ
Dr. Aric Logsdon Joins Psycheceutical Bioscience, Inc. as Company’s Scientific Director	29/22/29	GL
Dr. Aric Logsdon Joins Psycheceutical Bioscience, Inc. as Company’s Scientific Director	29/22/29	AQ
Mannatech is Reinventing Hydration Introduces Exclusive Blue Water	07/22/07	AQ
Psycheceutical Bioscience, Inc. Announces Medical Advisory Board	18/22/18	GL
Psycheceutical Bioscience, Inc. Announces Medical Advisory Board	18/22/18	AQ
Kevin Harrington, Original Shark from Shark Tank and Futurist Zappy Zapolin to Open Wonderland 2022	05/22/05	NE
Psycheceutical Bioscience, Inc.'s Zappy Zapolin Added to The Benzinga Psychedelics Advisory Council	04/22/04	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Blue Water Ventures International, Inc.

Equities

BWVI

US09609E1055

Press Releases

Filters